SOME ASPECTS OF METABOLIC CHANGES IN HYPERPROLACTINEMIA OF TUMOUR AND NON-TUMOUR GENESIS
Objective: SOME ASPECTS OF METABOLIC CHANGES IN HYPERPROLACTINEMIA OF TUMOUR AND NON-TUMOUR GENESIS Methods: It has been established that in patients with hyperprolactinemia, especially with pituitary prolactinoma, there is a predisposition to the development of the osteopenic syndrome. Refinemen...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Avicenna Tajik State Medical University
2018-12-01
|
| Series: | Паёми Сино |
| Subjects: | |
| Online Access: | https://doi.org/10.25005/2074-0581-2018-20-4-448-454 |
| Summary: | Objective: SOME ASPECTS OF METABOLIC CHANGES IN HYPERPROLACTINEMIA OF TUMOUR AND NON-TUMOUR GENESIS
Methods: It has been established that in patients with hyperprolactinemia, especially with pituitary prolactinoma, there is a predisposition to the development of the osteopenic syndrome. Refinement of the study of bone tissue remodelling processes revealed the predominance of resorption processes over bone formation processes, which, as a result, leads to disruption of bone tissue microarchitectonics. The most common variant of dyslipidemia in the metabolic syndrome is the lipid triad: hypertriglyceridemia, a low level of high-density lipoproteins and an increase in the level of low-density lipoproteins.
Results: A decrease in bone density according to densitometry and changes in calcium-phosphorus metabolism were detected in 47 (36.4%) patients (40 with pituitary adenoma and 7 without adenoma). Changes in the content of ionized Ca in serum were observed in 14 (29.9%) patients of the main group. A direct correlation was found between the level of prolactin and the C-terminal telopeptide (r=0.5284; p<0.05) and the inverse relationship between prolactin and osteocalcin (r=-0.4015; p<0.05). The degree of increase in the activity of ALAT and ASAT correlated with an increased level of prolactin (r=0.758; p<0.05). The correlation between the atherogenic coefficient and the level of prolactin revealed a positive pattern (r=0.822; p<0.05). Ultrasound revealed fatty hepatosis in 52 (40%) people, of whom 45 (34.6%) had different degrees of obesity. A study of liver biopsy specimens in 9 showed that in most cases (n=7) there was a minimal or moderate degree of fatty degeneration of hepatocytes.
Conclusion: It has been established that in patients with hyperprolactinemia, especially with pituitary prolactinoma, there is a predisposition to the development of the osteopenic syndrome. Refinement of the study of bone tissue remodelling processes revealed the predominance of resorption processes over bone formation processes, which, as a result, leads to disruption of bone tissue microarchitectonics. The most common variant of dyslipidemia in the metabolic syndrome is the lipid triad: hypertriglyceridemia, a low level of high-density lipoproteins and an increase in the level of low-density lipoproteins. |
|---|---|
| ISSN: | 2074-0581 2959-6327 |